March 27, 2018 — The U.S. Food and Drug Administration (FDA) has cleared Siemens Healthineers’ Mammomat Revelation premium mammography platform with the new InSpect integrated specimen imaging tool and the new HD Breast Biopsy solution for one-click targeting of suspicious areas. These and other features are designed to expand precision medicine and improve the patient experience.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now